Expanding horizons in Parkinson’s disease care with non-pharmacological interventions

The field of non-pharmacological interventions for the treatment of individuals with Parkinson’s disease (PD) is reaching maturity and has the potential to substantially improve patient care in the future.

Replicate Bioscience takes aim at mono-causing virus after promising results with mRNA rabies shot

Replicate Bioscience, a San Diego startup developing a second-generation mRNA vaccine technology that could spur stronger immunity with smaller doses, said its experimental rabies shots

February 15, 2024

Appeals court rules in favor of FDA regulating certain stem cell clinics more strictly

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

October 1, 2024

Novo Nordisk celebrates landmark Wegovy study, even as supply issues persist

The release of Novo Nordisk’s latest earnings report on Thursday provided a chance for executives to tout their major win this week — outcomes from

August 10, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.